Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Nov-22 9:00 PM View:  | Josephson Neil Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 10-Nov-22 | Planned Option Sale | 2,475 | $8.10 | $20,045.00 | (15%) 16.92K to 14.45K | |
| 14-Nov-22 9:00 PM View: | Josephson Neil Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 10-Nov-22 | Option Exercise | 5,885 | -- | -- | 53% 11.04K to 16.92K | |
| 05-Jul-22 9:00 PM View: | Josephson Neil Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 05-Jul-22 | Grant | 1,525 | $4.51 | $6,877.75 | 16% 9.51K to 11.04K | |
| 05-Jul-22 9:00 PM View: | Klompas Neil A Chief Operating Officer | Zymeworks Bc Inc. (ZYME) | 05-Jul-22 | Grant | 1,525 | $4.51 | $6,877.75 | 11% 13.98K to 15.5K | |
| 11-Mar-22 9:00 PM View: | Klompas Neil A Chief Operating Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-22 | Planned Option Sale | 2,979 | $6.88 | $20,495.50 | (18%) 16.95K to 13.98K | |
| 11-Mar-22 9:00 PM View: | Josephson Neil Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-22 | Option Exercise | 2,395 | -- | -- | 34% 7.12K to 9.51K | |
| 11-Mar-22 9:00 PM View: | Klompas Neil A Chief Operating Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-22 | Option Exercise | 5,208 | -- | -- | 44% 11.75K to 16.95K | |
| 11-Jan-22 9:47 PM View: | Josephson Neil Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 07-Jan-22 | Market Purchase | 5,000 | $14.28 | $71,386.00 | 236% 2.12K to 7.12K | < 1% |
| 07-Jan-22 9:30 PM View: | Josephson Neil Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 07-Jan-22 | Grant | 65 | $13.94 | $906.10 | 3% 2.05K to 2.12K | < 1% |
| 07-Jan-22 9:30 PM View: | Klompas Neil A Chief Operating Officer & CFO | Zymeworks Bc Inc. (ZYME) | 07-Jan-22 | Grant | 277 | $13.94 | $3,861.38 | 2% 11.47K to 11.75K | < 1% |
| 07-Jan-22 9:30 PM View: | Polverino Anthony J. Chief Scientific Officer | Zymeworks Bc Inc. (ZYME) | 07-Jan-22 | Grant | 74 | $13.94 | $1,031.56 | < 1% 36.33K to 36.41K | < 1% |
| 02-Sep-21 8:00 PM View: | Polverino Anthony J. Chief Scientific Officer | Zymeworks Bc Inc. (ZYME) | 31-Aug-21 | Option Exercise | 4,900 | $15.00 | $73,500.00 | 16% 31.43K to 36.33K | |
| 16-Jul-21 9:30 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 16-Jul-21 | Market Option Sale (Planned) | 41,191 | $36.00 | $1,482,880.00 | (12%) 357.03K to 315.84K | |
| 16-Jul-21 9:30 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 16-Jul-21 | Option Exercise | 41,191 | $4.26 | $175,651.00 | 13% 315.84K to 357.03K | |
| 16-Jul-21 9:30 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 15-Jul-21 | Option Exercise | 3,800 | $4.27 | $16,230.90 | 1% 315.84K to 319.64K | |
| 16-Jul-21 9:30 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 15-Jul-21 | Market Option Sale (Planned) | 3,800 | $36.00 | $136,800.00 | (1%) 319.64K to 315.84K | |
| 13-Jul-21 8:00 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 12-Jul-21 | Market Option Sale (Planned) | 12,669 | $36.12 | $457,635.00 | (4%) 328.5K to 315.84K | |
| 13-Jul-21 8:00 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 12-Jul-21 | Option Exercise | 12,669 | $4.31 | $54,555.20 | 4% 315.84K to 328.5K | |
| 08-Jul-21 8:00 PM View: | Priour James Chief Commercial Officer | Zymeworks Bc Inc. (ZYME) | 06-Jul-21 | Grant | 510 | $29.49 | $15,039.90 | 25% 2.0K to 2.51K | |
| 08-Jul-21 8:00 PM View: | Josephson Neil Interim Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 06-Jul-21 | Grant | 461 | $29.49 | $13,594.90 | 29% 1.59K to 2.05K | |
| 08-Jul-21 8:00 PM View: | Polverino Anthony J. Chief Scientific Officer | Zymeworks Bc Inc. (ZYME) | 06-Jul-21 | Grant | 454 | $29.49 | $13,388.50 | 1% 30.98K to 31.43K | |
| 08-Jul-21 8:00 PM View: | Klompas Neil A Chief Financial Officer | Zymeworks Bc Inc. (ZYME) | 06-Jul-21 | Grant | 299 | $29.49 | $8,817.51 | 3% 11.17K to 11.47K | |
| 08-Jul-21 8:05 PM View: | O'Driscoll Kathryn Chief People Officer | Zymeworks Bc Inc. (ZYME) | 06-Jul-21 | Grant | 510 | $29.49 | $15,039.90 | 9% 5.84K to 6.35K | |
| 13-Apr-21 9:30 PM View: | Priour James Chief Commercial Officer | Zymeworks Bc Inc. (ZYME) | 13-Apr-21 | Option Exercise | 2,266 | -- | -- | 330% 0.69K to 2.95K | |
| 13-Apr-21 9:30 PM View: | Priour James Chief Commercial Officer | Zymeworks Bc Inc. (ZYME) | 13-Apr-21 | Market Option Sale (Planned) | 950 | $27.93 | $26,533.10 | (32%) 2.95K to 2.0K | |
| 17-Mar-21 8:00 PM View: | O'Driscoll Kathryn Chief People Officer | Zymeworks Bc Inc. (ZYME) | 15-Mar-21 | Market Option Sale | 786 | $34.72 | $27,289.90 | (12%) 6.63K to 5.84K | 3% |
| 17-Mar-21 8:00 PM View: | O'Driscoll Kathryn Chief People Officer | Zymeworks Bc Inc. (ZYME) | 15-Mar-21 | Option Exercise | 837 | $34.24 | $28,658.90 | 14% 5.79K to 6.63K | (1%) |
| 12-Mar-21 8:00 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Market Option Sale (Planned) | 4,392 | $34.95 | $153,516.00 | (1%) 320.23K to 315.84K | |
| 12-Mar-21 8:00 PM View: | Polverino Anthony J. Chief Scientific Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Option Exercise | 2,500 | -- | -- | 8% 29.53K to 32.03K | |
| 12-Mar-21 8:00 PM View: | Klompas Neil A Chief Financial Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Option Exercise | 2,500 | -- | -- | 25% 10.1K to 12.6K | |
| 12-Mar-21 8:00 PM View: | Klompas Neil A Chief Financial Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Market Option Sale (Planned) | 1,425 | $34.95 | $49,808.70 | (11%) 12.6K to 11.17K | |
| 12-Mar-21 8:00 PM View: | O'Driscoll Kathryn Chief People Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Market Option Sale (Planned) | 568 | $34.95 | $19,853.60 | (9%) 6.36K to 5.79K | |
| 12-Mar-21 8:00 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Option Exercise | 7,708 | -- | -- | 2% 312.52K to 320.23K | |
| 12-Mar-21 8:00 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Market Option Sale (Planned) | 1,048 | $34.95 | $36,631.30 | (12%) 8.43K to 7.38K | |
| 12-Mar-21 8:00 PM View: | O'Driscoll Kathryn Chief People Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Option Exercise | 1,354 | -- | -- | 27% 5.0K to 6.36K | |
| 12-Mar-21 8:00 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Option Exercise | 2,500 | -- | -- | 42% 5.92K to 8.43K | |
| 12-Mar-21 8:00 PM View: | Polverino Anthony J. Chief Scientific Officer | Zymeworks Bc Inc. (ZYME) | 10-Mar-21 | Market Option Sale (Planned) | 1,048 | $34.95 | $36,631.30 | (3%) 32.03K to 30.98K | |
| 16-Feb-21 8:21 PM View: | O'Driscoll Kathryn Chief People Officer | Zymeworks Bc Inc. (ZYME) | 12-Feb-21 | Option Exercise | 2,083 | $34.24 | $71,321.90 | 71% 2.92K to 5.0K | |
| 11-Jan-21 5:04 PM View: | Klompas Neil A Chief Financial Officer | Zymeworks Bc Inc. (ZYME) | 08-Jan-21 | Grant | 284 | $30.92 | $8,781.28 | 3% 9.82K to 10.11K | |
| 11-Jan-21 5:04 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 07-Jan-21 | Grant | 207 | $30.92 | $6,400.44 | 4% 5.72K to 5.92K | |
| 11-Jan-21 5:06 PM View: | Polverino Anthony J. Chief Scientific Officer | Zymeworks Bc Inc. (ZYME) | 07-Jan-21 | Grant | 48 | $30.92 | $1,484.16 | < 1% 29.48K to 29.53K | |
| 11-Dec-20 7:30 PM View: | Klompas Neil A Chief Financial Officer | Zymeworks Bc Inc. (ZYME) | 09-Dec-20 | Option Exercise | 25,000 | $5.18 | $129,399.00 | 255% 9.82K to 34.82K | |
| 11-Dec-20 7:30 PM View: | Klompas Neil A Chief Financial Officer | Zymeworks Bc Inc. (ZYME) | 09-Dec-20 | Market Option Sale | 25,000 | $53.25 | $1,331,130.00 | (72%) 34.82K to 9.82K | 6% |
| 09-Dec-20 7:35 PM View: | Tehrani Ali Chief Executive Officer Director | Zymeworks Bc Inc. (ZYME) | 07-Dec-20 | Market Sale | 850 | $56.16 | $47,736.00 | (< 1%) 313.37K to 312.52K | 11% |
| 04-Dec-20 7:45 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 04-Dec-20 | Market Option Sale (Planned) | 6,032 | $55.12 | $332,476.00 | (51%) 11.75K to 5.72K | 9% |
| 04-Dec-20 7:45 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 04-Dec-20 | Option Exercise | 6,032 | $10.89 | $65,661.90 | 105% 5.72K to 11.75K | |
| 03-Dec-20 7:54 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 02-Dec-20 | Option Exercise | 701 | $11.47 | $8,043.30 | 12% 5.72K to 6.42K | |
| 03-Dec-20 7:54 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 02-Dec-20 | Market Option Sale (Planned) | 701 | $55.01 | $38,563.00 | (11%) 6.42K to 5.72K | 9% |
| 03-Dec-20 7:54 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 01-Dec-20 | Market Option Sale (Planned) | 18,267 | $55.19 | $1,008,240.00 | (76%) 23.98K to 5.72K | 9% |
| 03-Dec-20 7:54 PM View: | Hausman Diane Chief Medical Officer | Zymeworks Bc Inc. (ZYME) | 01-Dec-20 | Option Exercise | 18,267 | $11.38 | $207,955.00 | 319% 5.72K to 23.98K |
